{"id":"https://openalex.org/W2097961554","doi":"https://doi.org/10.1158/0008-5472.can-04-1350","title":"Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome","display_name":"Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome","publication_year":2004,"publication_date":"2004-08-15","ids":{"openalex":"https://openalex.org/W2097961554","doi":"https://doi.org/10.1158/0008-5472.can-04-1350","mag":"2097961554","pmid":"https://pubmed.ncbi.nlm.nih.gov/15313888"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-04-1350","doi":"https://doi.org/10.1158/0008-5472.can-04-1350","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-04-1350","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.vumc.nl/en/publications/81cb3368-a207-4ce9-9eed-bee84734f274","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010979808","display_name":"Martine E.D. Chamuleau","orcid":"https://orcid.org/0000-0002-0123-9182","observed_orcids":["https://orcid.org/0000-0002-0123-9182"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Martine E. D. Chamuleau","raw_affiliation_strings":["1Hematology, Departments of","Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands. m.chamuleau@vumc.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hematology, Departments of","institution_ids":[]},{"raw_affiliation_string":"Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands. m.chamuleau@vumc.nl","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014820060","display_name":"Yuri Souwer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Yuri Souwer","raw_affiliation_strings":["3Pathology, VU University Medical Center, Amsterdam, the Netherlands;","4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;","5Department of Immunopathology, Sanquin Research at Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pathology, VU University Medical Center, Amsterdam, the Netherlands;","institution_ids":["https://openalex.org/I911458345"]},{"raw_affiliation_string":"4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"5Department of Immunopathology, Sanquin Research at Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009731605","display_name":"S. Marieke van Ham","orcid":"https://orcid.org/0000-0003-1999-9494","observed_orcids":["https://orcid.org/0000-0003-1999-9494"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S. Marieke van Ham","raw_affiliation_strings":["4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083596009","display_name":"Adri Zevenbergen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Adri Zevenbergen","raw_affiliation_strings":["1Hematology, Departments of","VU medisch centrum;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hematology, Departments of","institution_ids":[]},{"raw_affiliation_string":"VU medisch centrum;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031160909","display_name":"Theresia M. Westers","orcid":"https://orcid.org/0000-0002-6504-3058","observed_orcids":["https://orcid.org/0000-0002-6504-3058"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theresia M. Westers","raw_affiliation_strings":["1Hematology, Departments of","Hematology laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hematology, Departments of","institution_ids":[]},{"raw_affiliation_string":"Hematology laboratory","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010117898","display_name":"Johannes Hans Berkhof","orcid":"https://orcid.org/0000-0003-2094-2380","observed_orcids":["https://orcid.org/0000-0003-2094-2380"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Berkhof","raw_affiliation_strings":["2Clinical Epidemiology and Biostatistics, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Clinical Epidemiology and Biostatistics, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056537893","display_name":"Chris J.L.M. Meijer","orcid":"https://orcid.org/0000-0002-2758-9463","observed_orcids":["https://orcid.org/0000-0002-2758-9463","https://orcid.org/0000-0001-8058-1404"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Chris J. L. M. Meijer","raw_affiliation_strings":["3Pathology, VU University Medical Center, Amsterdam, the Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pathology, VU University Medical Center, Amsterdam, the Netherlands;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013460374","display_name":"Arjan A. van de Loosdrecht","orcid":"https://orcid.org/0000-0001-8311-983X","observed_orcids":["https://orcid.org/0000-0001-8311-983X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arjan A. van de Loosdrecht","raw_affiliation_strings":["1Hematology, Departments of","Hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hematology, Departments of","institution_ids":[]},{"raw_affiliation_string":"Hematology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108882243","display_name":"Gert Jan Ossenkoppele","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gert J. Ossenkoppele","raw_affiliation_strings":["1Hematology, Departments of","Hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hematology, Departments of","institution_ids":[]},{"raw_affiliation_string":"Hematology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9555,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.86104282,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"64","issue":"16","first_page":"5546","last_page":"5550"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6187000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6187000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.3452000021934509,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clip","display_name":"CLIP","score":0.7829999923706055},{"id":"https://openalex.org/keywords/hla-dm","display_name":"HLA-DM","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hla-do","display_name":"HLA-DO","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hla-dr","display_name":"HLA-DR","score":0.9810000061988831},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9049999713897705},{"id":"https://openalex.org/keywords/myeloid-blasts","display_name":"myeloid blasts","score":0.7300000190734863},{"id":"https://openalex.org/keywords/mhc-class-ii-antigen-presentation","display_name":"MHC class II antigen presentation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cd4-t-cell-activation","display_name":"CD4+ T cell activation","score":0.8420000076293945},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9269999861717224},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9369999766349792}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6365399956703186},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.5487204790115356},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5311749577522278},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5215294361114502},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.5181818604469299},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.47621211409568787},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.465131938457489},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.45940059423446655},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4381265640258789},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4339821934700012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43111518025398254},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3890867233276367},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3693888485431671},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36732637882232666},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.3189639449119568},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25662219524383545}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006681","descriptor_name":"HLA-D Antigens","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D006681","descriptor_name":"HLA-D Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1158/0008-5472.can-04-1350","doi":"https://doi.org/10.1158/0008-5472.can-04-1350","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-04-1350","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:15313888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15313888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/aff9e7ab-efdb-43b5-b1b7-a25b4fc423a9","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/class-iiassociated-invariant-chain-peptide-expression-on-myeloid-leukemic-blasts-predicts-poor-clinical-outcome(aff9e7ab-efdb-43b5-b1b7-a25b4fc423a9).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer research, 64(16), 5546 - 5550. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/26127","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/26127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"64","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/2d55008c-871b-4546-a449-34131ad3b28d","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2d55008c-871b-4546-a449-34131ad3b28d","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Chamuleau, M E D, Souwer, Y, van Ham, S M, Zevenbergen, A, Westers, T M, Berkhof, J, Meijer, C J L M, van de Loosdrecht, A A & Ossenkoppele, G J 2004, 'Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome', Cancer research, vol. 64, no. 16, pp. 5546-5550. https://doi.org/10.1158/0008-5472.CAN-04-1350","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu2:oai:dare.ubvu.vu.nl:1871/26127","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/26127","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research, 64(16), 5546","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/81cb3368-a207-4ce9-9eed-bee84734f274","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/81cb3368-a207-4ce9-9eed-bee84734f274","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research, 64(16), 5546 - 5550. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:vumc:oai:pure.atira.dk:publications/81cb3368-a207-4ce9-9eed-bee84734f274","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/81cb3368-a207-4ce9-9eed-bee84734f274","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research, 64(16), 5546 - 5550. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1643239212","https://openalex.org/W1880826209","https://openalex.org/W1968052999","https://openalex.org/W2033659941","https://openalex.org/W2034350731","https://openalex.org/W2046854756","https://openalex.org/W2072541256","https://openalex.org/W2091686762","https://openalex.org/W2092847969","https://openalex.org/W2095352046","https://openalex.org/W2097252142","https://openalex.org/W2112936194","https://openalex.org/W2115182182","https://openalex.org/W2124368817","https://openalex.org/W2125652931","https://openalex.org/W2126622826","https://openalex.org/W2152953925","https://openalex.org/W2154277549","https://openalex.org/W2166972035","https://openalex.org/W4232560691","https://openalex.org/W4245608028"],"related_works":["https://openalex.org/W7096139667","https://openalex.org/W6964974826","https://openalex.org/W2554135508","https://openalex.org/W2563235307","https://openalex.org/W2117205260","https://openalex.org/W2565599151","https://openalex.org/W2056373410","https://openalex.org/W1968405942","https://openalex.org/W2168484579","https://openalex.org/W3108355811"],"abstract_inverted_index":{"Effective":[0],"antitumor":[1,186],"responses":[2],"need":[3],"the":[4,16,26,63,86,148],"activation":[5],"of":[6,18,65,76,88,147,158],"CD4+":[7,177],"T":[8,178],"cells.":[9],"MHC":[10],"class":[11,19],"II":[12],"antigen":[13,34,66],"presentation":[14],"requires":[15],"release":[17],"II-associated":[20],"invariant":[21],"chain":[22],"peptide":[23],"(CLIP)":[24],"from":[25],"antigen-binding":[27],"site.":[28],"In":[29,45],"antigen-presenting":[30,145],"cells,":[31,47,121],"human":[32],"leukocyte":[33],"DM":[35,38,51,155],"(HLA-DM;":[36],"abbreviated":[37],"in":[39,143,161,189],"this":[40],"article)":[41],"catalyzes":[42],"CLIP":[43,159],"dissociation.":[44],"B":[46],"HLA-DO":[48],"(DO)":[49],"down-modulates":[50],"function.":[52],"Cell":[53],"surface":[54],"CLIP:HLA-DR":[55],"(DR)":[56],"ratio":[57,61,135],"correlates":[58],"to":[59,116,119,137,172,176],"DO:DM":[60,134],"and":[62,72,92,154,184],"efficacy":[64],"presentation.":[67],"We":[68,164],"examined":[69],"111":[70],"blood":[71],"bone":[73],"marrow":[74],"samples":[75],"patients":[77,108],"with":[78,98,109],"newly":[79],"diagnosed":[80],"acute":[81],"myeloid":[82],"leukemia":[83],"(AML)":[84],"for":[85],"expression":[87,160],"CLIP,":[89],"DR,":[90],"DM,":[91],"DO":[93,153],"by":[94,131],"flow":[95],"cytometry.":[96],"Patients":[97],"DR+/CLIP-":[99,167],"blasts":[100,169],"had":[101],"a":[102,190],"significant":[103],"longer":[104],"disease-free":[105,192],"survival":[106],"than":[107],"DR+/CLIP+":[110],"blasts.":[111,163],"DO,":[112],"until":[113],"now":[114],"believed":[115],"be":[117,123],"restricted":[118],"lymphoid":[120],"could":[122],"demonstrated":[124],"at":[125],"protein":[126],"level":[127],"as":[128,130],"well":[129],"reverse":[132],"transcription-PCR.":[133],"correlated":[136],"CLIP:DR":[138],"ratio,":[139],"suggesting":[140],"that,":[141],"unlike":[142],"other":[144],"cells":[146,180],"nonlymphoid":[149],"cell":[150],"type,":[151],"both":[152],"mediate":[156],"regulation":[157],"AML":[162,168],"hypothesize":[165],"that":[166],"are":[170],"able":[171],"present":[173],"leukemia-specific":[174],"antigens":[175],"helper":[179],"initiating":[181],"an":[182],"effective":[183],"long-lasting":[185],"response":[187],"resulting":[188],"prolonged":[191],"survival.":[193]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}